Found 9 matching trials
Two Dose Levels of Privigen in Pediatric CIDP
PHASE4A randomized, open-label, prospective, multicenter study designed to invest...
Location
Phoenix Children's Hospital
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
PHASE3The purpose of this study is to evaluate the efficacy, tolerability and saf...
Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)
PHASE2This randomized, multicenter, double-blind (DB), placebo controlled, phase ...
Location
Mayo Clinic Arizona - Scottsdale
A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)
PHASE4It is known that intravenous immunoglobulins can induce hemolysis, but the ...
Location
UMHAT "Dr. Georgi Stranski" Clinic of Haematology
Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
PHASE3The objectives of this trial are the assessment of safety and efficacy of I...
Location
Contact CSL Behring for facility details
Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
PHASE3The objective of this study is to demonstrate the efficacy and safety of Pr...
Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
PHASE3The purpose of this study is to demonstrate the effect of IgPro10 on the pr...
Location
Multiple Locations
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)
PHASE3This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Location
Site reference 8400181
Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)
PHASE2This is a prospective, multicenter, randomized, open-label, crossover study...
Location
Royal Adelaide Hospital